265 related articles for article (PubMed ID: 32960304)
41. Variants and Pitfalls of PET/CT in Neuroendocrine Tumors.
Imperiale A; Meuter L; Pacak K; Taïeb D
Semin Nucl Med; 2021 Sep; 51(5):519-528. PubMed ID: 33838874
[TBL] [Abstract][Full Text] [Related]
42. [Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors].
Pellat A; Barat M; Cottereau AS; Terris B; Coriat R
Bull Cancer; 2023 Sep; 110(9):955-967. PubMed ID: 36935319
[TBL] [Abstract][Full Text] [Related]
43. An update on the development of concepts, diagnostic criteria, and challenging issues for neuroendocrine neoplasms across different digestive organs.
Couvelard A; Cros J
Virchows Arch; 2022 Jun; 480(6):1129-1148. PubMed ID: 35278097
[TBL] [Abstract][Full Text] [Related]
44. [Analysis of primary site and pathology on 903 patients with neuroendocrine neoplasms].
Qiu X; Liu M; Liu Q; Yang Z; Liu J; Meng F; Wang Z; Shi Y; Liu L; Zhang P; Luo J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):993-996. PubMed ID: 28900988
[TBL] [Abstract][Full Text] [Related]
45. Relation between WHO Classification and Location- and Functionality-Based Classifications of Neuroendocrine Neoplasms of the Digestive Tract.
Helderman NC; Suerink M; Kilinç G; van den Berg JG; Nielsen M; Tesselaar MET
Neuroendocrinology; 2024; 114(2):120-133. PubMed ID: 37690447
[TBL] [Abstract][Full Text] [Related]
46. Clinical usefulness of Somatostatin Receptor Scintigraphy in the Diagnosis of Neuroendocrine Neoplasms.
Inaba Y; Hijioka S; Iwama I; Asai T; Miyamura H; Chatani S; Hasegawa T; Murata S; Kato M; Sato Y; Yamaura H; Onaya H; Shimizu J; Hara K
Asia Ocean J Nucl Med Biol; 2022; 10(1):1-13. PubMed ID: 35083344
[TBL] [Abstract][Full Text] [Related]
47. [Clinical features and prognostic factors of primary gastric neuroendocrine neoplasms].
Xiong YJ; Liu XY; Cheng CE; Chen C; Sun YB; Tan CH; Liu YT; Feng J; Ma YF; Shi DT; Li R; Tang QY
Zhonghua Nei Ke Za Zhi; 2020 Apr; 59(4):297-302. PubMed ID: 32209196
[No Abstract] [Full Text] [Related]
48. [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].
Klöppel G
Pathologe; 2015 May; 36(3):237-45. PubMed ID: 25947223
[TBL] [Abstract][Full Text] [Related]
49. Role of positron emission tomography in thyroid and neuroendocrine tumors.
Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
[TBL] [Abstract][Full Text] [Related]
50. Neuroendocrine neoplasm imaging: protocols by site of origin.
Martin S; Iravani A; Shetty AS; Zulfiqar M; Morani A; Yano M; Bhosale PR; Itani M
Abdom Radiol (NY); 2022 Dec; 47(12):4081-4095. PubMed ID: 36307597
[TBL] [Abstract][Full Text] [Related]
51. Imaging of Pancreatic Neuroendocrine Neoplasms.
Chiti G; Grazzini G; Cozzi D; Danti G; Matteuzzi B; Granata V; Pradella S; Recchia L; Brunese L; Miele V
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501485
[TBL] [Abstract][Full Text] [Related]
52. An Update on Gastroenteropancreatic Neuroendocrine Neoplasms: From Mysteries to Paradigm Shifts.
Ramírez-Rentería C; Ferreira-Hermosillo A; Marrero-Rodríguez D; Taniguchi-Ponciano K; Melgar-Manzanilla V; Mercado M
Arch Med Res; 2020 Nov; 51(8):765-776. PubMed ID: 32654882
[TBL] [Abstract][Full Text] [Related]
53. A relook at gastroenteropancreatic neuroendocrine tumours as per 2019 WHO classification-A tertiary centre experience.
Ail DA; Paulose RR
Ir J Med Sci; 2023 Oct; 192(5):2065-2070. PubMed ID: 36409421
[TBL] [Abstract][Full Text] [Related]
54. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
[TBL] [Abstract][Full Text] [Related]
55. Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?
Parra-Medina R; Moreno-Lucero P; Jimenez-Moreno J; Parra-Morales AM; Romero-Rojas A
PLoS One; 2019; 14(5):e0216647. PubMed ID: 31086397
[TBL] [Abstract][Full Text] [Related]
56. Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy.
Chougnet CN; Leboulleux S; Caramella C; Lumbroso J; Borget I; Déandreis D; Duvillard P; Elias D; de Baere T; Vélayoudom-Céphise FL; Guigay J; Ducreux M; Schlumberger M; Baudin E
Endocr Relat Cancer; 2013 Apr; 20(2):229-39. PubMed ID: 23404855
[TBL] [Abstract][Full Text] [Related]
57. Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas.
Patel N; Barbieri A; Gibson J
Surg Pathol Clin; 2019 Dec; 12(4):1021-1044. PubMed ID: 31672292
[TBL] [Abstract][Full Text] [Related]
58. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Yin F; Wu ZH; Lai JP
World J Gastroenterol; 2022 May; 28(17):1751-1767. PubMed ID: 35633912
[TBL] [Abstract][Full Text] [Related]
59. Clinical Usefulness of
Rinzivillo M; Partelli S; Prosperi D; Capurso G; Pizzichini P; Iannicelli E; Merola E; Muffatti F; Scopinaro F; Schillaci O; Salgarello M; Falconi M; Delle Fave G; Panzuto F
Oncologist; 2018 Feb; 23(2):186-192. PubMed ID: 29118267
[TBL] [Abstract][Full Text] [Related]
60. 68Ga-DOTANOC PET/CT Detects a Rare Case of Metastatic Neuroendocrine Neoplasm of the Gallbladder.
Kumar A; Kumar B; Muthu GS; Mitra S
Clin Nucl Med; 2022 Jun; 47(6):539-540. PubMed ID: 35384899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
